NEW YORK (GenomeWeb) – Allele Biotechnology & Pharmaceuticals today announced it has formed a commercial business to bank human induced pluripotent stem cells by private individuals. 

The San Diego-based firm said that in addition to providing a service to its customers, the iPSC bank will be a resource to biomedical researchers. With consent given by the bank's customers, thousands of iPSC lines — along with accompanying sequence database and health information — will be made available to scientists and clinicians. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.